Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 3/20 | 0.39 |
| ▸ | CFTR | P13569 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5589567 | 0.95 | HPGD (0.42) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL5587630 | 0.93 | HPGD (0.41) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL5587663 | 0.93 | HPGD (0.41) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL5589634 | 0.89 | HPGD (0.41) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL5587173 | 0.87 | ALOX5 (0.39) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL5590103 | 0.85 | ALOX5 (0.41) | TYMPKDM4EALDH1A1HSD17B10ALOX5 | |
| SCHEMBL5592667 | 0.85 | ALOX5 (0.41) | TYMPKDM4EALDH1A1HSD17B10ALOX5 | |
| SCHEMBL5588251 | 0.85 | ALOX5 (0.41) | TYMPKDM4EALDH1A1HSD17B10ALOX5 | |
| SCHEMBL5587783 | 0.85 | ALOX5 (0.41) | TYMPKDM4EALDH1A1HSD17B10ALOX5 | |
| SCHEMBL5588597 | 0.85 | ALOX5 (0.41) | TYMPKDM4EALDH1A1HSD17B10ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461072-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | HPGD 2689/4885NPC1 3851/4885MAPK1 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.